Viewing data from:

LISDEXAMFETAMINE DIMESYLATE

ANDA

LISDEXAMFETAMINE DIMESYLATE | A216266 | PRINSTON PHARMACEUTICAL INC

7 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: VYVANSE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 7 NDCs

Highest NADAC/Unit

$2.81

per ea

Lowest NADAC/Unit

$2.60

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
43547060710LISDEXAMFETAMINE 60 MG CAPSULE	$2.81	EA	Generic	—	2026-08-19
43547060810LISDEXAMFETAMINE 70 MG CAPSULE	$2.76	EA	Generic	—	2026-08-19
43547060610LISDEXAMFETAMINE 50 MG CAPSULE	$2.70	EA	Generic	—	2026-08-19
43547060410LISDEXAMFETAMINE 30 MG CAPSULE	$2.66	EA	Generic	—	2026-08-19
43547060210LISDEXAMFETAMINE 10 MG CAPSULE	$2.66	EA	Generic	—	2026-08-19
43547060510LISDEXAMFETAMINE 40 MG CAPSULE	$2.63	EA	Generic	—	2026-08-19
43547060310LISDEXAMFETAMINE 20 MG CAPSULE	$2.60	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain9 active DMFs1 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

VERANOVA LPLISDEXAMFETAMINE DIMESYLATE

DMF 224422009

CHATTEM CHEMICALS INCLISDEXAMFETAMINE DIMESYLATE

DMF 322892018

SPECGX LLCLISDEXAMFETAMINE DIMESYLATE

DMF 348232020

NORAMCO LLCLISDEXAMFETAMINE DIMESYLATE DRUG SUBSTANCE

DMF 356452021

AUGUST PHARMACEUTICALS LLCLISDEXAMFETAMINE DIMESYLATE INT

DMF 357542021

ALKEM LABORATORIES LTDLISDEXAMFETAMINE DIMESYLATE

DMF 386672023

VERANOVA LPLISDEXAMFETAMINE DIMESYLATE B1625

DMF 388742023

GRANULES INDIA LTDLISDEXAMFETAMINE DIMESYLATE

DMF 417372025

COHANCE LIFESCIENCES LTDLISDEXAMFETAMINE

DMF 422822025

SPECGX LLCInactiveLISDEXAMFETAMINE DIMESYLATE

DMF 322102017

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.